Fudan Zheng, PhD

Principal scientist
Johnson & Johnson Innovative Medicine

Poster(s):

• (M-030) Observed and Simulated Pharmacokinetics and Pharmacodynamics of Nipocalimab in Adults with Sjögren’s Disease: Results from a Phase 2, Multicenter, Randomized, Placebo-controlled Study
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT

• (S-008) Population PK-RO-IgG Modeling of Nipocalimab in Patients with Sjögren's Disease
  Sunday, October 19, 2025

  7:00 AM - 5:00 PM MDT